A Phase III Randomized, Placebo-Controlled Trial Evaluating Memantine IND 149832 for Neurocognitive Protection in Children Undergoing Cranial Radiotherapy as Part of Treatment for Primary Central Nervous System Tumors

Brief Summary

Type:
Brain Tumors / Neurologic Cancers

Study Type:
Supportive Care

Phase:
III

ClinicalTrials.gov Identifier:
NCT04939597

Study #:
CMH - ACCL2031

Start Date:
Dec 08, 2021

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04939597

View Complete Trial Details & Eligibility at ClinicalTrials.gov